Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Silence Therapeutics PLC Sponsored ADR (SLN) had Operating Margin of -3729.15% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.42M |
|
$-14.96M |
|
$0.01M |
|
$0.41M |
|
$16.16M |
|
$-15.74M |
|
$0.78M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-15.74M |
|
$-15.63M |
|
47.23M |
|
47.23M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$102.85M |
|
$1.40M |
|
$12.27M |
|
$115.12M |
|
$10.46M |
|
$0.04M |
|
$55.26M |
|
$65.72M |
|
$-49.40M |
|
$38.80M |
|
$49.40M |
|
47.23M |
|
| Cash Flow Statement Financials | |
$-15.60M |
|
$10.00M |
|
-- |
|
$11.28M |
|
$5.66M |
|
$-5.62M |
|
$2.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.83 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
97.39% |
|
|
Operating Margin |
-3729.15% |
-3729.15% |
|
-- |
|
-3544.31% |
|
-3544.31% |
|
$-15.60M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
4738.01 |
|
30.28% |
|
-38.55% |
|
-12.99% |
|
-30.25% |
|
$1.05 |
|
$-0.33 |
|
$-0.33 |
|